M1 Kliniken AG

M1 Kliniken AG: Management Board confirms growth targets

M1 Kliniken AG: Attila Strauss, sell

M1 Kliniken announces change in the Management Board and confirms long-term growth strategy

M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024

M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics

M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share

M1 Kliniken AG decides to start share buyback

M1 Kliniken AG publishes preliminary figures for financial year 2023: M1 continues to grow – sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million

M1 Kliniken AG: Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024

Management Board of M1 Kliniken AG acquires 1.5 million shares in the company and plans an uplisting to the Prime Standard

M1 Kliniken AG: Kilian Brenske, buy

M1 Kliniken AG: Attila Strauss, buy

M1 Kliniken AG: Attila Strauss, sell

Invitation to the virtual AlsterResearch Healthcare Pop-Up Conference on 23 January 2024 at 1:30 pm

M1 Kliniken AG Acquires Online Pharmacy and Secures Long-Term Procurement Advantages

M1 Kliniken AG publishes figures for the third quarter 2023: Further strong growth and doubling of the operating result

M1 Kliniken AG: Market leader for beauty medicine in Germany opens up in the 9th foreign market and prepares market entry in the USA

M1 Kliniken AG publishes figures for the first half year 2023:

M1 Kliniken AG publishes Q1 figures 2023: Strong growth and disproportionate increase in operating result

M1 Kliniken AG: Attila Strauss, buy

M1 Kliniken AG: Kilian Brenske, buy

M1 Kliniken AG decides to start share buyback

M1 Kliniken AG publishes preliminary figures for financial year 2022

M1 Kliniken AG: Kilian Brenske, buy

M1 Kliniken AG: Attila Strauss, buy

Expansion of the Management Board of M1 Kliniken AG

Expansion of the Management Board of M1 Kliniken AG

M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market

M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate

M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment